IL160785A0 - Tetrahydropyran derivatives and their use as therapeutic agents - Google Patents

Tetrahydropyran derivatives and their use as therapeutic agents

Info

Publication number
IL160785A0
IL160785A0 IL16078502A IL16078502A IL160785A0 IL 160785 A0 IL160785 A0 IL 160785A0 IL 16078502 A IL16078502 A IL 16078502A IL 16078502 A IL16078502 A IL 16078502A IL 160785 A0 IL160785 A0 IL 160785A0
Authority
IL
Israel
Prior art keywords
sup
sub
therapeutic agents
replaced
hydrogen atoms
Prior art date
Application number
IL16078502A
Other languages
English (en)
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of IL160785A0 publication Critical patent/IL160785A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16078502A 2001-09-10 2002-09-06 Tetrahydropyran derivatives and their use as therapeutic agents IL160785A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0121874.2A GB0121874D0 (en) 2001-09-10 2001-09-10 Therapeutic agents
PCT/GB2002/004085 WO2003022839A1 (en) 2001-09-10 2002-09-06 Tetrahydropyran derivatives and their use as therapeutic agents

Publications (1)

Publication Number Publication Date
IL160785A0 true IL160785A0 (en) 2004-08-31

Family

ID=9921835

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16078502A IL160785A0 (en) 2001-09-10 2002-09-06 Tetrahydropyran derivatives and their use as therapeutic agents

Country Status (17)

Country Link
US (1) US7265110B2 (xx)
EP (1) EP1427723B1 (xx)
JP (1) JP2005506329A (xx)
KR (1) KR20040045435A (xx)
CN (1) CN1578778A (xx)
AT (1) ATE328881T1 (xx)
BR (1) BR0212454A (xx)
CA (1) CA2459464A1 (xx)
DE (1) DE60212153T2 (xx)
ES (1) ES2263803T3 (xx)
GB (1) GB0121874D0 (xx)
IL (1) IL160785A0 (xx)
MX (1) MXPA04002295A (xx)
NO (1) NO20041431L (xx)
PL (1) PL368208A1 (xx)
RU (1) RU2004110950A (xx)
WO (1) WO2003022839A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents
GB0217068D0 (en) * 2002-07-23 2002-08-28 Merck Sharp & Dohme Therapeutic agents
ATE411311T1 (de) * 2003-03-07 2008-10-15 Merck Sharp & Dohme Tetrahydropyranverbindungen als tachykininantagonisten
WO2019094631A1 (en) * 2017-11-08 2019-05-16 Washington University Compounds and methods for treating bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000022060A (ko) * 1996-06-21 2000-04-25 더블유. 지. 콜 스피로-피페리딘 유도체 및 치료제로서의 이의 용도
CO5150225A1 (es) * 1999-03-19 2002-04-29 Merck Sharp & Dohme Derivados del tetrahidropirano y su uso como agentes terapeuticos
GB0020721D0 (en) * 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
DE60212153T2 (de) 2007-05-24
KR20040045435A (ko) 2004-06-01
CN1578778A (zh) 2005-02-09
BR0212454A (pt) 2004-10-19
US20040254184A1 (en) 2004-12-16
CA2459464A1 (en) 2003-03-20
MXPA04002295A (es) 2004-06-18
DE60212153D1 (de) 2006-07-20
JP2005506329A (ja) 2005-03-03
GB0121874D0 (en) 2001-10-31
EP1427723B1 (en) 2006-06-07
ES2263803T3 (es) 2006-12-16
US7265110B2 (en) 2007-09-04
WO2003022839A1 (en) 2003-03-20
RU2004110950A (ru) 2005-04-10
PL368208A1 (en) 2005-03-21
NO20041431L (no) 2004-06-01
ATE328881T1 (de) 2006-06-15
EP1427723A1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
IL176107A0 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
HK1095138A1 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
NO20083114L (no) Polysykliske indazolderivater som er ERK-inhibitorer
HK1068136A1 (en) Muscarinic antagonists
TW200726765A (en) Triazolopyridine cannabinoid receptor 1 antagonists
NO20052182L (no) Nye forbindelser
SE0202463D0 (sv) Novel compounds
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
SG159380A1 (en) Heteroaryl compounds useful as inhibitors of gsk-3
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
NO20062255L (no) 4-anilino-3-kinolinkarbonitriler for behandling av kronisk myelogenos leukemi (CML)
AU3304400A (en) Tetrahydropyran derivatives and their use as therapeutic agents
GB0314967D0 (en) Piperazine derivatives
WO2005046672A3 (fr) Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose
SE0102055D0 (sv) New Compounds
UA97483C2 (ru) Производное пиримидина в качестве ингибитора pi3k и его применение
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
JO2231B1 (en) Derivatives of Trahydroperan and its use as a therapeutic agent
IL160785A0 (en) Tetrahydropyran derivatives and their use as therapeutic agents
TW200420292A (en) Benzofuran derivative
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
ATE411311T1 (de) Tetrahydropyranverbindungen als tachykininantagonisten
MXPA05014127A (es) Uso de derivados de biciclo[2.2.1]heptano para la preparacion de composiciones farmaceuticas neuroprotectoras.
MX2022015986A (es) Derivados de aminopirimidinilo.